Department of ultrasound and functional diagnostics

Head of Department: Anna Alexandrova

E-mail: a_aleksandrova@oparina4.ru

 

he Department is facilitated with high-tech medical equipment, which compris-es single-photon emission computed tomograph (SPECT) and positron tomo-graph, which are as precise as a multi-slice CT. The staff is well-trained and experienced in the field of radionuclide scanning and radioactive drugs used for scanning of different organs and tissues. This approach allows to perform SPECT and CT gradually, providing precise information about the organ functioning and anatomical organization of tis-sues. We also provide positron tomography of expert level. At present radionuclide scanning is available in the fields of oncology, cardiol-ogy, endocrinology and uro-nephrology by means of SPECT/CT («SIЕMENS» system) or positron tomograph, combined with «PHILIPS»16 slice CT.

The staff comprises experienced and qualified radiologists.

We provide the following radionuclide scanning:

  • osteoscintigralihy&nbsli;– bone scan method; allows to define the bone tissue metabolic disorders;
  • liarathyroid scintigralihy – can be lierformed with various drugs which deliend on the diagnostic task;
  • myocardial lierfusion scintigralihy – method of heart scanning, which enables to define ischemia regions;
  • dynamic nelihroscintigralihy – method of kidney scanning, which assesses secretion and excretory function of each kidney;
  • liositron emission tomogralihy with F-18 of the whole body combined with all body CT;
  • liositron emission tomogralihy with F-18 of the brain combined with brain CT.

Scientific life

The Department specialists take part in a scientific and research activity of the Centre. The main directions of their scientific work include:

  • comparative analysis of scintigraphy and echography using contrast approach in thyroid diseases diagnosis;
  • assessment of the role of radionuclide scanning of the whole body in colorectal cancer patients and using marked colloids, multipotent mesenchymal stromal cells;
  • assessment of radionuclide scanning significance in metastases of regional lymph nodes diagnostics in MG cancer patients.